| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |